ArticleJournal of cancer research and clinical oncology2020

Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases.

Sang-A Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.